Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes.

Takenaka K, Yamagishi S, Matsui T, Nakamura K, Jinnouchi Y, Yoshida Y, Ueda S, Katsuki Y, Katsuda Y, Imaizumi T.

Atherosclerosis. 2008 Mar;197(1):25-33. Epub 2007 Sep 11.

PMID:
17850801
2.

Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).

Yamagishi S, Matsui T, Takenaka K, Nakamura K, Takeuchi M, Inoue H.

Diabetes Metab Res Rev. 2009 Mar;25(3):266-71. doi: 10.1002/dmrr.906.

PMID:
19165765
3.

Pigment epithelium-derived factor (PEDF) inhibits collagen-induced platelet activation by reducing intraplatelet nitrotyrosine levels.

Yamagishi S, Matsui T, Nakamura K, Takenaka K.

Int J Cardiol. 2010 Apr 1;140(1):121-2. doi: 10.1016/j.ijcard.2008.11.015. Epub 2008 Nov 29.

PMID:
19046781
4.

Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.

Jinnouchi Y, Yamagishi S, Matsui T, Takenaka K, Yoshida Y, Nakamura K, Ueda S, Imaizumi T.

Brain Res. 2007 Sep 5;1167:92-100. Epub 2007 Jul 10.

PMID:
17692294
5.

Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.

Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.

Nephrol Dial Transplant. 2009 May;24(5):1397-406. doi: 10.1093/ndt/gfn659. Epub 2008 Nov 28.

PMID:
19042927
6.

Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation.

Nakamura K, Yamagishi S, Matsui T, Yoshida T, Takenaka K, Jinnouchi Y, Yoshida Y, Ueda S, Adachi H, Imaizumi T.

Am J Pathol. 2007 Jun;170(6):2159-70.

7.

Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.

Yoshida Y, Yamagishi S, Matsui T, Jinnouchi Y, Fukami K, Imaizumi T, Yamakawa R.

Diabetes Metab Res Rev. 2009 Oct;25(7):678-86. doi: 10.1002/dmrr.1007.

PMID:
19685553
8.

Administration of pigment epithelium-derived factor prolongs bleeding time by suppressing plasminogen activator inhibitor-1 activity and platelet aggregation in rats.

Yamagishi S, Matsui T, Nakamura K, Takenaka K.

Clin Exp Med. 2009 Mar;9(1):73-6. doi: 10.1007/s10238-008-0010-4. Epub 2008 Sep 25.

PMID:
18815870
9.

Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats.

Yamagishi S, Matsui T, Ueda S, Takeuchi M.

Int J Cardiol. 2010 Oct 8;144(2):283-5. doi: 10.1016/j.ijcard.2009.01.071. Epub 2009 Feb 23.

PMID:
19237211
10.

Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction.

Ueda S, Yamagishi S, Matsui T, Jinnouchi Y, Imaizumi T.

Am J Pathol. 2011 Feb;178(2):591-8. doi: 10.1016/j.ajpath.2010.10.018.

11.

Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.

Yamagishi S, Inagaki Y, Nakamura K, Abe R, Shimizu T, Yoshimura A, Imaizumi T.

J Mol Cell Cardiol. 2004 Aug;37(2):497-506.

PMID:
15276019
12.

Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.

Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T.

Ophthalmic Res. 2007;39(2):92-7. Epub 2007 Feb 2.

PMID:
17284935
13.

Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.

Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T.

Cell Tissue Res. 2005 Jun;320(3):437-45. Epub 2005 Apr 22.

PMID:
15846509
14.

Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.

Amano S, Yamagishi S, Inagaki Y, Nakamura K, Takeuchi M, Inoue H, Imaizumi T.

Microvasc Res. 2005 Jan;69(1-2):45-55.

PMID:
15797260
15.

Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties.

Seki R, Yamagishi S, Matsui T, Yoshida T, Torimura T, Ueno T, Sata M, Okamura T.

Biochem Biophys Res Commun. 2013 Feb 22;431(4):693-7. doi: 10.1016/j.bbrc.2013.01.057. Epub 2013 Jan 31.

PMID:
23375814
16.

Pigment epithelium-derived factor (PEDF) blocks angiotensin II-induced T cell proliferation by suppressing autocrine production of interleukin-2.

Yamagishi S, Kikuchi S, Nakamura K, Matsui T, Takeuchi M, Inoue H.

Med Chem. 2006 May;2(3):265-9.

PMID:
16948472
17.

Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.

Ide Y, Matsui T, Ishibashi Y, Takeuchi M, Yamagishi S.

Microvasc Res. 2010 Sep;80(2):227-32. doi: 10.1016/j.mvr.2010.03.015. Epub 2010 Apr 8.

PMID:
20381502
18.

Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes.

Sheikpranbabu S, Haribalaganesh R, Gurunathan S.

Diabetes Metab. 2011 Dec;37(6):505-11. doi: 10.1016/j.diabet.2011.03.006. Epub 2011 Jun 1.

PMID:
21636306
19.

Pigment epithelium-derived factor (PEDF) blocks the interleukin-6 signaling to C-reactive protein expression in Hep3B cells by suppressing Rac-1 activation.

Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Inoue H, Ueno T, Sata M.

Life Sci. 2006 Oct 19;79(21):1981-7. Epub 2006 Jun 29.

PMID:
16876827
20.

Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells.

Matsui T, Higashimoto Y, Taira J, Yamagishi S.

Biochem Biophys Res Commun. 2013 Nov 15;441(2):405-10. doi: 10.1016/j.bbrc.2013.10.074. Epub 2013 Oct 23.

PMID:
24161393

Supplemental Content

Support Center